Impedance Cardiology Systems develops cardiovascular monitoring systems for patients with congestive heart failure.
Impedance Cardiology Systems, Inc. engages in biotechnology and is based in Menlo Park, California.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 29, 2006 | Series B | $5M | 1 |
Versant Ventures
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
Yes | Series B |